A share price of Cardiol Therapeutics Inc [CRDL] is currently trading at $1.31, down -2.24%. An important factor to consider is whether the stock is rising or falling in short-term value. The CRDL shares have gain 32.87% over the last week, with a monthly amount glided 10.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardiol Therapeutics Inc [NASDAQ: CRDL] stock has seen the most recent analyst activity on June 02, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $9. Previously, Rodman & Renshaw started tracking the stock with Buy rating on January 28, 2025, and set its price target to $7. On June 26, 2024, ROTH MKM initiated with a Buy rating and assigned a price target of $10 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $9 on April 22, 2024.
Cardiol Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.77 and $2.63. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Cardiol Therapeutics Inc [NASDAQ: CRDL] shares were valued at $1.31 at the most recent close of the market. An investor can expect a potential return of 510.69% based on the average CRDL price forecast.
Analyzing the CRDL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.41, Equity is -2.1 and Total Capital is -1.48. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2667 points at the first support level, and at 1.2234 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3866, and for the 2nd resistance point, it is at 1.4632.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cardiol Therapeutics Inc [NASDAQ:CRDL] is 2.46. On the other hand, the Quick Ratio is 2.46, and the Cash Ratio is 3.01.
